Detalhe da pesquisa
1.
Clinical significance of L1CAM expression in metastatic tubo-ovarian high-grade serous carcinoma.
Gynecol Oncol
; 176: 76-81, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37478615
2.
The phosphatase PTPN1/PTP1B is a candidate marker of better chemotherapy response in metastatic high-grade serous carcinoma.
Cytopathology
; 32(2): 161-168, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33025675
3.
Expression of palladin is associated with disease progression in metastatic high-grade serous carcinoma.
Cytopathology
; 31(6): 572-578, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32741023
4.
SOX2 and SOX9 are markers of clinically aggressive disease in metastatic high-grade serous carcinoma.
Gynecol Oncol
; 153(3): 651-660, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30904337
5.
Expression, activation and clinical relevance of CHK1 and CHK2 in metastatic high-grade serous carcinoma.
Gynecol Oncol
; 150(1): 136-142, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29804637
6.
L1CAM as a prognostic marker in stage I endometrial cancer: a validation study.
BMC Cancer
; 16: 596, 2016 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27488577
7.
CIAPIN1 and ABCA13 are markers of poor survival in metastatic ovarian serous carcinoma.
Mol Cancer
; 14: 44, 2015 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-25889687
8.
Expression and clinical role of chemoresponse-associated genes in ovarian serous carcinoma.
Gynecol Oncol
; 139(1): 30-9, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26232338
9.
Wee1 is a novel independent prognostic marker of poor survival in post-chemotherapy ovarian carcinoma effusions.
Gynecol Oncol
; 135(1): 118-24, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25093290
10.
Occludin is overexpressed in tubo-ovarian high-grade serous carcinoma compared to mesothelioma and is a marker of tumor progression and chemoresistance.
Clin Exp Metastasis
; 41(1): 69-76, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38141113
11.
Molecular characteristics of tubo-ovarian carcinosarcoma at different anatomic locations.
Virchows Arch
; 2024 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38733380
12.
Migfilin, α-parvin and ß-parvin are differentially expressed in ovarian serous carcinoma effusions, primary tumors and solid metastases.
Gynecol Oncol
; 128(2): 364-70, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23099104
13.
Gene expression signatures differentiate uterine endometrial stromal sarcoma from leiomyosarcoma.
Gynecol Oncol
; 128(2): 349-55, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23178314
14.
HOXB8 expression in ovarian serous carcinoma effusions is associated with shorter survival.
Gynecol Oncol
; 129(2): 358-63, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23438671
15.
Claudin-10 is a new candidate prognostic marker in metastatic high-grade serous carcinoma.
Virchows Arch
; 482(6): 975-982, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37067588
16.
Lymphovascular invasion and p16 expression are independent prognostic factors in stage I vulvar squamous cell carcinoma.
Virchows Arch
; 2023 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37843640
17.
Gene expression signatures differentiate ovarian/peritoneal serous carcinoma from breast carcinoma in effusions.
J Cell Mol Med
; 15(3): 535-44, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20132413
18.
Expression of the cancer stem cell marker SSEA1 is associated with poor survival in metastatic high-grade serous carcinoma.
Virchows Arch
; 477(5): 677-685, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32472195
19.
Death domain-associated protein (DAXX) expression is associated with poor survival in metastatic high-grade serous carcinoma.
Virchows Arch
; 477(6): 857-864, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32533344
20.
Chromosome Translocation t(14;21)(q11;q22) Activates Both OLIG1 and OLIG2 in Pediatric T-cell Lymphoblastic Malignancies and May Signify Adverse Prognosis.
Cancer Genomics Proteomics
; 17(1): 41-48, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31882550